glp 1 approved for type 1 diabetes The ABC's of GLP-1s: Benefits, Side Effects, and Success Stories — Nice Healthcare GLP-1-based therapies for diabetes, obesity

Accessed 20 Apr 2017 Stanley CA, Bennett MJ, Longo N (2014) Plasma membrane carnitine transporter defect, In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G (eds) The online metabolic and molecular bases of inherited disease New York, McGraw-Hill, New York

Pharmacoepidemiol Drug Saf (2002) 11(1):310

Lambeau KV, McRorie JW

Conversely, the M2 phenotype supports tissue repair and synaptic remodeling following the pro-inflammatory phase through the secretion of anti-inflammatory cytokines [i.e., IL-10 and transforming growth factor-beta (TGF-)]

Both effects rely on GLP-1 receptor activation, but they emerge on different timelines